SUPN SG&A Expense Growth
Supernus Pharmaceuticals Inc · SG&A Expense Growth
SUPN SG&A Expense Growth
Latest reported44.61%period ending
SUPN FY SG&A Growth (YoY) (0.00% → 44.61%)
Latest values, visible window
High-resolution chart · PNG
SUPN sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 44.6066% | |
| -0.1721% | |
| -10.8318% | |
| 23.7768% | |
| 51.8654% | |
| 26.67% | |
| -0.915% | |
| 15.9407% | |
| 30.0868% | |
| 18.84% | |
| 23.0892% | |
| 30.367% | |
| 176.1276% | |
| 153.9354% | |
| 56.063% | |
| 9.2708% | |
| 8.4441% | |
| 6.8626% | |
| 0% |